PYY-tag transgenic mice displaying abnormal (H+-K+)ATPase activity and gastric mucosal barrier impairment

Laboratory Investigation

Volumn 83, Issue 1, 2003, Pages 47-54

  Laforenza, Umberto ^a,e   Gastaldi, Giulia ^a   Rindi, Guido ^c   Leiter, Andrew B ^e   Cova, Emanuela ^a   Marchetti, Annalisa ^b   Candusso, Maria Elena ^a   Autelli, Michele ^b   Orsenigo, Maria Novella ^d   Ventura, Ulderico ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c UNIVERSITY OF PARMA   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

^e TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 NITROPHENYLPHOSPHATASE; AMINOPHENAZONE; CALCIUM CHANNEL L TYPE; CARBON 14; GASTRIN; GASTROINTESTINAL HORMONE; GLUCAGON; HYDROGEN POTASSIUM ADENOSINE TRIPHOSPHATASE; INSULIN; OXYNTOMODULIN; PEPTIDE YY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APICAL MEMBRANE; ARTICLE; CELL PROLIFERATION; COLON TUMOR; CONTROLLED STUDY; DIET RESTRICTION; DNA CONTENT; ENDOCRINE TUMOR; ENZYME ACTIVITY; HISTOPATHOLOGY; HORMONAL REGULATION; INCIDENCE; MEMBRANE VESICLE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTON TRANSPORT; STOMACH ACID SECRETION; STOMACH FUNCTION; STOMACH MUCOSA LESION; STOMACH PH; STOMACH ULCER; TRANSGENIC MOUSE;

EID: 0037239427     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.LAB.0000048720.34096.D7     Document Type: Article

References (51)

1. Adrian TE, Savage AP, Sagor GR, Allen JM, Bacarese-Hamilton AJ, Tatemoto K, Polak JM, and Bloom SR (1985). Effect of peptide YY on gastric, pancreatic, and biliary function in humans. Gastroenterology 89:494-499.
2. Anini Y, Fu-Cheng X, Cuber JC, Kervran A, Chariot J, and Rozé C (1999). Comparison of the postprandial release of peptide YY and proglucagon-derived peptides in the rat. Pflügers Arch 438:299-306.
3. Beales IL and Calam J (1996). Truncated glucagon-like peptide-1 and oxyntomodulin stimulate somatostatin release from rabbit fundic D-cells in primary culture. Exp Physiol 81:1039-1041.
4. Brubaker PL (1991). Regulation of intestinal proglucagon-derived peptide secretion by intestinal regulatory peptides. Endocrinology 128:3175-3182.
5. Brubaker PL, Lee YC, and Drucker DJ (1992). Alterations in proglucagon processing and inhibition of proglucagon gene expression in transgenic mice which contain a chimeric proglucagon-SV40 T antigen gene. J Biol Chem 267:20728-20733.
6. Carmosino M, Calamita G, Mazzone A, Laforenza U, Rindi G, Leiter AB, Svelto M, and Valenti G (2001). Reduced expression of the aquaporin 4 water channel in PYY transgenic mice stomach. Pflügers Arch 442:R12.
7. Corne SJ, Morrissey SM, and Woods RJ (1974). Proceedings: A method for the quantitative estimation of gastric barrier mucus. J Physiol (London) 242:116P-117P.
8. Dembinski A, Gregory H, Konturek SJ, and Polanski M (1982). Trophic action of epidermal growth factor on the pancreas and gastroduodenal mucosa in rats. J Physiol (London) 325:35-42.
9. Drucker DJ (2001). Glucagon-like peptide 2. J Clin Endocrinol Metab 86:1759-1764.
10. Drucker DJ, Erlich P, Asa SL, and Brubaker PL (1996). Induction of intestinal epithelial proliferation by glucagon-like peptide 2. Proc Natl Acad Sci USA 93:7911-7916.
11. El-Salhy M, Suhr O, and Danielsson Å (2002). Peptide YY in gastrointestinal disorders. Peptides 23:397-402.
12. Fleck A and Begg D (1954). The estimation of ribonucleic acid using ultraviolet absorption measurements. Biochim Biophys Acta 108:333-339.
13. Forte JG, Black JA, Forte TM, Machen TE, and Wolosin JM (1981). Ultrastructural changes related to functional activity in gastric oxyntic cells. Am J Physiol 241:G349-G358.
14. Gastaldi G, Laforenza U, Ferrari G, Casasco A, and Rindi G (1992). Age-related thiamin transport by small intestinal microvillous vesicles of rat. Biochim Biophys Acta 1105:271-277.
15. Gastaldi G, Laforenza U, Verri A, Candusso ME, Rindi G, Leiter AB, and Ventura U (2000). Gastric mucosal barrier alterations in Pyy-Tag mice. Pflügers Arch 439:R257.
16. Giles KW and Myers A (1965). An improved diphenylamine method for the estimation of deoxyribonucleic acid. Nature 206:93.
17. Goodlad RA, Gathei MA, Bloom SR, and Wright NA (1991). Glucagon 1-21 reduces intestinal epithelial cell proliferation in parenterally fed rats. Exp Physiol 76:943-949.
18. Grimelius L (1968). A silver nitrate stain for alpha-2 cells in human pancreatic islets. Acta Soc Med Ups 73:243-270.
19. Gros L, Hollande F, Thorens B, Kervran A, and Bataille D (1995). Comparative effects of GLP-1-(7-36) amide, oxyntomodulin and glucagon on rabbit gastric parietal cell function. Eur J Pharmacol 288:319-327.
20. Guo YS, Fujimura M, Lluis F, Tsong Y, Greeley GH Jr, and Thompson JC (1987a). Inhibitory action of peptide YY on gastric acid secretion. Am J Physiol 253:G298-G302.
21. Guo YS, Singh P, Gomez G, Greeley GH Jr, and Thompson JC (1987b). Effect of peptide YY on cephalic, gastric, and intestinal phases of gastric acid secretion and on the release of gastrointestinal hormones. Gastroenterology 92:1202-1208.
22. Holst JJ. Enteroglucagon (1997). Annu Rev Physiol 59:257-271.
23. Igarashi S, Kume E, Narita H, and Kinoshita M (2000). Food deprivation depletes gastric mucus glycoprotein in streptozotocin-induced diabetic rats. Jpn J Pharmacol 84:51-55.
24. +)-ATPase. Biochim Biophys Acta 772:167-175.
25. Kirkegaard P, Moody AJ, Hoist JJ, Loud FB, Olsen PS, and Christiansen J (1982). Glicentin inhibits gastric acid secretion in the rat. Nature 297:156-157.
26. Korolkiewicz R, Tashima K, Kubomi M, Kato S, and Takeuchi K (1999). Increased susceptibility of diabetic rat gastric mucosa to food deprivation during cold stress. Digestion 60:528-537.
27. + transport in gastric mucosa of Pyy-Tag transgenic mice. Pflügers Arch 439:R258.
28. Langhans N, Rindi G, Chiu M, Rehfeld JF, Ardman B, Beinborn M, and Kopin AS (1997). Abnormal gastric histology and decreased acid production in cholecystokinin-B/gastrin receptor-deficient mice. Gastroenterology 112:280-286.
29. Lloyd KC, Grandt D, Aurang K, Eysselein VE, Schimiczek M, and Reeve JR Jr (1996). Inhibitory effect of PYY on vagally stimulated acid secretion is mediated predominantly by Y1 receptors. Am J Physiol 270:G123-G127.
30. Lowry OH, Rosebrough NJ, Farr AL, and Randall RJ (1951). Protein measurements with the Folin phenol reagent. J Biol Chem 193:265-275.
31. Mannon PJ (2002). Peptide YY as a growth factor for intestinal epithelium. Peptides 23:383-388.
32. Munroe DG, Gupta AK, Kooshesh F, Vyas TB, Rizkalla G, Wang H, Demchyshyn L, Yang ZJ, Kamboj RK, Chen H, McCallum K, Sumner-Smith M, Drucker DJ, and Crivici A (1999). Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2. Proc Natl Acad Sci USA 96:1569-1573.
33. Pappas TN, Debas HT, Chang AM, and Taylor IL (1986). Peptide YY release by fatty acids is sufficient to inhibit gastric emptying in dogs. Gastroenterology 91:1386-1389.
34. Plaisancié P, Dumoulin V, Chayvialle JA, and Cuber JC (1996). Luminal peptide YY-releasing factors in the isolated vascularly perfused rat colon. J Endocrinol 151:421-429.
35. +-ATPase-containing membranes from the gastric oxyntic cell. Methods Enzymol 192:151-165.
36. Rindi G, Necchi V, Savio A, Torsello A, Zoli M, Locatelli V, Raimondo F, Cocchi D, and Solcia E (2002). Characterisation of gastric ghrelin cells in man and other mammals: studies in adult and fetal tissues. Histochem Cell Biol 117:511-519.
37. Rindi G, Paolotti D, Fiocca R, Wiedenmann B, Henry J-P, and Solcia E (2000). Vesicular monoamine transporter 2 as a marker of gastric enterochromaffin-like cell tumors. Virchows Arch 436:217-223.
38. Robert A (1987). Effect of drugs on gastric secretion. In: Johnson LR, editor. Physiology of the gastrointestinal tract. New York: Raven, 1071-1088.
39. Sheikh SP (1991). Neuropeptide Y and peptide YY: Major modulators of gastrointestinal blood flow and function. Am J Physiol 261:G701-G715.
40. Tsai CH, Hill M, and Drucker DJ (1997). Biological determinants of intestinotrophic properties of GLP-2 in vivo. Am J Physiol 272:G662-G628.
41. Tseng WW and Liu CD (2002). Peptide YY and cancer: Current findings and potential clinical applications. Peptides 23:389-395.
42. Upchurch BH, Aponte GW, and Leiter AB (1994). Expression of peptide YY in all four islet cell types in the developing mouse pancreas suggests a common peptide YY-producing progenitor. Development 120:245-252.
43. Upchurch BH, Fung BP, Rindi G, Ronco A, and Leiter AB (1996). Peptide YY expression is an early event in colonic endocrine cell differentiation: Evidence from normal and transgenic mice. Development 122:1157-1163.
44. Urushidani T and Forte JG (1997). Signal transduction and activation of acid secretion in the parietal cell. J Membrane Biol 159:99-111.
45. Wøjdemann M, Wettergren A, Hartmann B, Hilsted L, and Holst JJ (1999). Inhibition of sham feeding-stimulated human gastric acid secretion by glucagon-like peptide-2. J Clin Endocrinol Metab 84:2513-2517.
46. Walsh JH (1994). Gastrointestinal hormones. In: Johnson LR, editor. Physiology of the gastrointestinal tract. New York: Raven, 1-128.
47. Wettergren A, Maina P, Boesby S, and Holst JJ (1997). Glucagon-like peptide-1 7-36 amide and peptide YY have additive inhibitory effect on gastric acid secretion in man. Scand J Gastroenterol 32:552-555.
48. Wettergren A, Petersen H, Orskov C, Christiansen J, Sheikh SP, and Holst JJ (1994). Glucagon-like peptide-1 7-36 amide and peptide YY from the L-cell of the ileal mucosa are potent inhibitors of vagally induced gastric acid secretion in man. Scand J Gastroenterol 29:501-505.
49. Yang H (2002). Central and peripheral regulation of gastric acid secretion by peptide YY. Peptides 23:349-358.
50. Yusta B, Huang L, Munroe D, Wolff G, Fantaske R, Sharma S, Demchyshyn L, Asa SL, and Drucker DJ (2000). Enteroendocrine localization of GLP-2 receptor expression in humans and rodents. Gastroenterology 119:744-755.
51. Zeng N, Walsh JH, Kang T, Wu SV, and Sachs G (1997). Peptide YY inhibition of rat gastric enterochromaffin-like cell function. Gastroenterology 112:127-135.